chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blurry vision; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75 year-old female patient received bnt162b2 (BNT162B2), administration date 24Mar2021 (Lot number: ER8730) at the age of 75 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Diabetes mellitus" (unspecified if ongoing), notes: Verbatim: Diabetes. Concomitant medication(s) included: METFORMIN taken for diabetes mellitus (ongoing). Vaccination history included: Covid-19 (Lot# for the first shot: EN6202), for COVID-19 immunisation. The following information was reported: VISION BLURRED (non-serious), outcome "unknown", described as "Blurry vision". Therapeutic measures were not taken as a result of vision blurred.  No follow-up attempts are possible. No further information is expected.
At 12 hrs post vaccination,  I had a headache. The next day, nausea and a headache.  It took 3-5 days to feel completely back to normal.  Estimated date of delivery is 08/2021  I am currently at 14 weeks gestation.
Following administration of my 2nd Covid-19 vaccine, I experienced common effects such as fever, extreme fatigue, and warmth/redness/swelling at the injection site, all of which resolved completely within 72 hours. However, about a month after that vaccine, I started having terrible tinnitus, which I've never experienced before. I passed it off as a sinus related issue, but it continued. It severely interferes with sleep, focus, and concentration. I'm a wife, mom, & Registered Nurse and this is definitely having a negative impact on my daily activities.
Dizziness, Headache, Myalgia, Fever, chills, joint pain, pain and discomfort in injection site Narrative:  Received vaccine on 2/5/21 started feeling ill on 2/7/21 and on 2/8/21 with fever, chills, body aches, HA, dizziness, joint pain, nausea, body pain, pain discomfort and redness and swelling in arm. Taking otc acetaminophen to help with body aches. Starting to feel better. Advised that is normal side effects of vaccine and should subside 203 days after the vaccine.  Other Relevant History:
my right shoulder was hurt it when I rotated cup it was 2 weeks prior and after the second sho; This is a spontaneous report from a Pfizer-sponsored program. A 76-years-old male patient (who is also a reporter) received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN5318), via an unspecified route of administration on 25Jan2021 as 1st dose, single for Covid-19 immunisation. Medical history included heart attack in 2000 and high blood pressure which he regulated with medications. Concomitant medications included patient took several medications. On an unknown date, patient reported his right shoulder was hurt it when he rotated cup it was 2 weeks prior and after the second shot started having problem, on his left shoulder really bad. The patient underwent lab tests and procedures which included blood cholesterol which was a normal blood work up for cholesterol and everything just a normal like a check-up for physical whatever all that is and result was reported as all came back good. The outcome of the event was unknown.
Tinnitus in right ear since getting vaccine. I got the shot in the right arm as well (may be unrelated). Unable to sleep with tinnitus. Nausea and little appetite, losing weight. All started the day I received the vaccine. There are days when tinnitus is lower level and no nausea, but it returns. Still like this almost 2 months later.
Pt had local reaction starting on 10-8-15 with reddened and swollen area at injection site. Then starting on 10-10-15 the pt experienced numbness and tingling bilateral hand and feet. Pt seen by physician assistant 10-12-15. Feet and hands were dusky in appearance and warm to the touch and capillary refill was normal. There was no pain or weakness. 10-13-15 pt states there is a little improvement with tingling and numbness today.
Caller is COVID positive after taking the first dose; Caller is COVID positive after taking the first dose; got sick; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration on 31Dec2020 at a single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included levothyroxine sodium (SYNTHROID), duloxetine hydrochloride (CYMBALTA), vitamin C, vitamin E, propanolol hcl and clonazepam (KLONOPIN). Reporter is a social worker at a community center for pediatrics. She had the first dose of the COVID-19 vaccine on 31Dec2020. However, she got sick past Sunday (03Jan2021) and tested positive for COVID-19. She was wondering if there is a chance that the vaccine caused the positive result for the COVID test. Consumer stated, "I had a question about the COVID vaccine and I had the COVID vaccine administered on let's say it was 31Dec and I felt sick over the weekend and ended up having to take a COVID test. Well, the COVID test came out positive for COVID. And so my question is because I had the vaccine could the vaccine maybe cause a false positive test?" The patient underwent lab tests and procedures which included SARS-COV-2 test: positive on an unspecified date (Caller is COVID positive after taking the first dose). The outcome of the events was unknown.
Tested positive for covid, Headache, Minimum loss of smell, Minimum loss of taste, Abdominal pain, Back pain, Diarrhea; Headache; loss of smell; Abdominal pain; Diarrhea; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (Tested positive for covid, Headache, Minimum loss of smell, Minimum loss of taste, Abdominal pain, Back pain, Diarrhea), HEADACHE (Headache), ANOSMIA (loss of smell), ABDOMINAL PAIN (Abdominal pain) and DIARRHOEA (Diarrhea) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced HEADACHE (Headache), ANOSMIA (loss of smell), ABDOMINAL PAIN (Abdominal pain) and DIARRHOEA (Diarrhea). On an unknown date, the patient experienced COVID-19 (Tested positive for covid, Headache, Minimum loss of smell, Minimum loss of taste, Abdominal pain, Back pain, Diarrhea). At the time of the report, COVID-19 (Tested positive for covid, Headache, Minimum loss of smell, Minimum loss of taste, Abdominal pain, Back pain, Diarrhea) outcome was unknown and HEADACHE (Headache), ANOSMIA (loss of smell), ABDOMINAL PAIN (Abdominal pain) and DIARRHOEA (Diarrhea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
This case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 56-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number XM2N7, expiry date 1st April 2024) for prophylaxis. On 1st June 2022, the patient received Boostrix (intramuscular). On 1st June 2022, unknown after receiving Boostrix, the patient experienced accidental underdose. On an unknown date, the outcome of the accidental underdose was unknown. Additional Information: GSK receipt date 1 June 2022: Reporter's comment: The pharmacy Tech reports needle leaked with Boostrix administration. Pharmacist predicts that patient only received 1/4 of the dose. The reporter consented to follow up. Additional Supportive Information: The patient received only received 1/4 of the dose of Boostrix due to needle leak which led to accidental underdose.
I developed vertigo about a week after my fourth dose. It lasted for about a week, but I still have the symptoms from time to time.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 60-year-old female patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020). On 18th April 2018, the patient received the 1st dose of SHINGRIX .5 ml. In April 2018, less than a week after receiving SHINGRIX, the patient experienced injection site erythema, fever and injection site pain. On 18th April 2018, the patient experienced pruritus. On an unknown date, the outcome of the injection site erythema, fever, injection site pain and pruritus were not recovered/not resolved. The reporter considered the injection site erythema, fever, injection site pain and pruritus to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX on left arm. The patient developed redness at injection  site, itchiness and soreness. It was reported that, the redness got worse and the patient had developed a low grade fever. The reporter declined to provide prescribed information or concomitant medications.
This is a spontaneous report from a noncontactable consumer (patient). A female patient, of an unspecified age, received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# not reported), via an unspecified route of administration, on Mar 10, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. On an unspecified date, the side of her face became swollen with red spots. The outcome of the events: unknown. No follow-up attempts possible. Information about lot/batch number cannot be obtained.
Patient brought to ED via EMS with cough and shortness of breath.  Diagnosed with COVID pneumonia after received 1st COVID vaccine.  Patient treated with oxygen, steroids, remdesivir, and antibiotics.  Patient recovered and was discharged to home.
Erythematous reaction 6cm deep red, surrounding pink halo of 2cm. and total induration of 15cm at site of varicella booster within 36 hours of receiving shot. Treated with cool compresses and Benadryl to itching.
2 days after the second shot, I began to have arm twitches/spasms that would come and go, daily for approximately 3 weeks. Once they stopped, I began getting small/micro facial spasms/twitches on my chin; daily and these continue every day, multiple times per day.
84 y.o. female with history of follicular lymphoma (completed rituxan Dec 2021, currently in remission), HTN, HLD, and CKD 3 who presents with generalized weakness.  Patient started feeling generally unwell about 1 week ago.  COVID testing obtained at that visit would later returned positive.
Rapid heart rate from 10:00pm 02/12/2020 to 12:30pm 02/13/2021
1/2 cm area erythema at vaccine site. No induration / fluctuance. 1 day after vaccine.
Sharp pain at injection site that persisted for 2 months.  Also with persistent cough for 2 months after injection. Symptoms started within 24 hours of injection.
Redness, swelling, warmth, tenderness and itch, 4x5cm/around shot site x3 weeks.
Not many side effects the day after, but had a large 5 inch by 5 inch red inflamed area near the site of injection. It was warm to the touch and has still been there since the date of injection
AFEBRILE - REDDNESS AND ERYTHEMA LEFT ARM DISTAL TO THE INJECTION SITE AREA - C/O HEADACHE AND MUSCLE ACHES - SAYS HER ARM WAS SIGNIFICANTLY MORE EDEMATOUS AND RED YESTERDAY
Provider that saw the patient, incorrectly diluted and administered a full vial of pfizer to the 4 year old patient. Mom read the form closely and started asking questions. Eventually it was discovered that the nurse practitioner had read the box containing the vials. She interpreted the instructions as "10 doses per box," and when she opened the box, there were 10 vials. She then diluted the vial per the instructions and administered the entire vial to the patient. The patient therefore received 10 doses of the recommended vaccine.
pt recvd Engerix-B vax 7JUL92 & approx 15 mins p/vax pt became hypotensive, faint, had to palpate BP was cyanotic around lips, pale, clammy, diaphoretic & cool to touch; also confused taken to hosp was shock-like;
Client presented  to receive Pfizer booster. Client informed RN that when she received Moderna vaccine dose 1 on 3/25/21 and dose 4/22/21. Client experienced a 102 fever with cold sores around her mouth and in the back of her ears,  the same night of vaccination. The cold sores lasted for about a week and the fever lasted 3 days. Cold sores were not itchy. She took Tylenol and antiviral meds. Client went to the Dr was told it was a normal vaccine reaction. Client has no history of allergies and no medical conditions. A medical consult was submitted by  RN to Clinical Project Coordinator Client received approval to receive Pfizer COVID vaccine Booster. Client received Pfizer Booster lot#FK9896. Client reported no symptoms during her 15min-observation period.
Within minutes of administering the influenza and HPV vaccine, the patient fainted. The patient experienced incontinence during this event. It took over an hour for the patient to recover. During the time of recovery, vitals were stable. Patient experienced severe headache, nausea and dizziness. Patient was given ZOFRAN, apple juice, crackers and water.
fever, chills, muscle aches, joint pain, headache, upset stomach, extreme fatigue, pain/swelling/heat at injection site. Symptoms lasted approx 24 hours. Only symptom remaining is arm swelling/redness/heat at injection site.
second dose (not yet administered) is more than 2 months due after the first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (second dose (not yet administered) is more than 2 months due after the first dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (second dose (not yet administered) is more than 2 months due after the first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (second dose (not yet administered) is more than 2 months due after the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.  Patient reported that her family received the first shot at the end of March and went out of town.   Reporter did not allow further contact
Patient received 1st Moderna vaccine on 8/11/2021 at 16 years and 10 months. Patient stated she was 18 and born in 2001.  After completing  A VAERS report was completed at this time for the first dose. Patient returned on 8/11/2021 for second vaccine. Our translator was present and explained to the father and patient in their language the recommendation from CDC to receive 2nd dose. They both expressed understanding and had no further questions. Patient was given vaccine and had no reaction while waiting the required time.
Pt experienced severe pain & edema in lt arm from shoulder to hand, & fever /p receiving Influenza Virus. Symptoms persisted for approx. 2 wks & pt recovered
Rash - Information has been received from a doctor of pharmacy concerning a 47 year old female who on 22 Jan 2001 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation 632048/0105k.  On 08 Feb 2001 the patient experienced red rash.  The patient sought medical attention.  The reporter noted that another woman received a vaccine dose from the same lot # and experienced a red rash waes 01031396.
Kinrix was given instead of Pediarix; Kinrix was given at the 6 month; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 6-month-old patient who received DTPa-IPV (Kinrix) for prophylaxis.   On an unknown date, the patient received Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: Kinrix was given instead of Pediarix) and inappropriate age at vaccine administration (Verbatim: Kinrix was given at the 6 month). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 20-JUN-2023 The Kinrix was given instead of Pediarix at the 6 month of age, which led to wrong vaccine administered and inappropriate age at vaccine administration. The reporter asked was there any harm from this? Did any vaccines need to be made up? The reporter did not consent to follow-up.
She felt aches and pain; She broke out in sweat; Also felt chills last night; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2, dose 2 via an unspecified route of administration on 10Feb2021 as single for COVID-19 immunisation. Medical history included pneumonia. The patient's concomitant medications were not reported. The patient experienced she felt aches and pain, she broke out in sweat and also felt chills last night on 11Feb2021. The patient reported that she got her second dose of the COVID vaccine on Wednesday 10Feb2021. She drank a lot of water and yesterday she felt aches and pain but last night she broke out in sweat. She took her temperature, and it was not really high. Last measure 45 min ago indicated 97 Fahrenheit. The patient underwent lab tests and procedures which included body temperature: 97 Fahrenheit on 12Feb2021. She used a steroid cream and also felt chills last night and she did not feel like that since she had pneumonia. Outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
91-year-old female with past medical history listed below admitted on 8/15/2022 for weakness.  Was residing in a nursing home and fell.  She was brought to the hospital for further evaluation, to have AKI.  Patient denies any headache, dizziness, chest pain, palpitations, shortness of breath, abdominal pain, nausea, vomiting, diarrhea, urinary symptoms. Reports that she has had decreased appetite for the last 2 weeks.  Did get the COVID vaccine about 3 weeks ago.  In the ED, was noted to have AKI.  She will be admitted for further evaluation and treatment
On Wednesday 10/4/2021 (2 days after my Pfizer booster shot) I had a bowel movement  and noticed a great deal of blood in the bowl. I was extremely nervous until I realized I had a similar experience 6 months earlier.  That?s when I had my second shot. I immediately googled ?Covid vaccine blood in spool?. The search returned Thrombocytopenia or a drop in platelets.  In both instances it only occurred once. Needless to say I was very relieved.
2/2/23 I have an exiting condition, PTSD, starting in 2001. I had boxes packed and had someone help me go through the boxes and had to expose myself to memories I was not expecting. My symptoms of PTSD began to worsen and exacerbate. I had to seek mental health help and am continuing in treatment.
There is a scab starting to develop on the very old scar.  It started off as just a few bumps but has not gone away and is getting worse - Till now, it covers the entire old scab area.
A red spot then a 5x2 inch rash; A spontaneous report  was received from a consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events red spot, 5x2 inch rash/Rash erythematous .  The patient's medical history includes allergy to seroquel. No relevant concomitant medications were reported.  On 16 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection.  On 16 Jan 2021, the patient experienced the event(s) red spot, 5x2 inch rash.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), red spot, 5x2 inch rash was unknown.
This spontaneous report as received from a nurse refers to a 4-month-old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 19-SEP-2017, the patient was vaccinated with improperly stored ROTATEQ (dosing details were not reported) (lot # M042170, expiry date: 22-JUN-2018) orally for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054.
Patient described pain in shoulder that received PNEUMOVAX and FLUVIRIN. The pain radiated to her neck and back. Also stated she could not move her arm.
patient was supposed to be receiving the updated covid pfizer bivalent and ended up receiving the monovalent
IM given in left arm 3rd dose (Booster). Moderna Covid-19 Vaccine Lot 045C21A given was removed from freezer on 10/6/21 @ 11:45 am. Given on 11/5/21, out of time range. Patient contacted that evening. Moderan manufacturer called. Patients called the following Monday letting them know that Moderna was looking into this and would be getting back to us. Also let them know I would be following up with them once we heard bak from them. Called patient today 11/17/21 and let him know that oderan let us know the vacine was viable, no additional booster vaccine is required.
After about 20 minutes of receiving the vaccine, the patient became slightly unconscious in the waiting area of the pharmacy. He began falling over in the chair and seemed very pale. His wife was with him and myself and two customers in the store were helping to keep him awake. 911 was called and did arrive. He was barely speaking at first and then when he was given oxygen by 911 he began to come to. His wife was stating that he had not eaten today. Paramedics took him to the hospital, he was awake and conscious when they took him.
12:00 AM: Sore Muscles, Nausea 04:30 AM: Vomiting, Fever (107.4 °F).  No treatment provided. Symptoms resolved naturally by 13:00 (1PM) 03/12/21.
Facial swelling occurred same day after administration. Puffy eyes, cheeks and mouth. Treated with over the counter Benadryl.
Uveitis in right eye flared 3 days after 1st vaccine, it resolved after few weeks of treatment. It flared again 3 days after 2nd dose of pfizer vaccine. It continues to flare 10 days after the 2nd dose and is being treated.